Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • Pharma Business
  • About us
    • Media Kit
    • Privacy Policy
  • Contact
4D pharma kicks off study of its candidate for asthma
July 8, 2019 Off

4D pharma kicks off study of its candidate for asthma

By Dino Mustafić

4D pharma has started with a multicentre Phase I/II double-blind, placebo-controlled study of MRx-4DP0004 in patients with poorly controlled asthma.

July 8, 2019 Off

AmerisourceBergen Announces Long-Term Strategic Relationship with OneOncology

By BusinessWire

OneOncology and AmerisourceBergen to Support Community Oncology Practices to Provide High-Quality Cancer Care to Patients Across the Nation VALLEY FORGE,…

July 8, 2019 Off

Ligand and SQ Innovation Enter into Exclusive Worldwide Captisol® License and Supply Agreements for High-Concentration Furosemide Formulation

By BusinessWire

SQ Innovation will use Ligand’s Captisol technology to achieve a smaller delivery volume for more cost-effective diuretic treatment in heart…

Lannett to distribute Levothyroxine Sodium tablets in USA
July 8, 2019 Off

Lannett to distribute Levothyroxine Sodium tablets in USA

By Dino Mustafić

Lannett Company has entered into a future exclusive supply and distribution agreement for the approved Levothyroxine Sodium Tablets USP of Cediprof, Inc., a wholly owned subsidiary of privately held Neolpharma Pharmaceutical Group.

Launching of Lung Ambition Alliance aims to double five-year survival in lung cancer in 6 years
July 8, 2019 Off

Launching of Lung Ambition Alliance aims to double five-year survival in lung cancer in 6 years

By Dino Mustafić

Astrazeneca has entered partnership with the International Association for the Study of Lung Cancer (IASLC), Guardant Health, the Global Lung Cancer Coalition (GLCC) named the Lung Ambition Alliance, to try to eliminate lung cancer as a cause of death.

July 8, 2019 Off

Compass Therapeutics Announces First Patient Dosed in Phase 1 Trial of CTX-471

By BusinessWire

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Compass Therapeutics, a clinical-stage biotechnology company targeting the human immune synapse with a new generation of monoclonal and…

July 8, 2019 Off

Compass Therapeutics Announces First Patient Dosed in Phase 1 Trial of CTX-471

By BusinessWire

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Compass Therapeutics, a clinical-stage biotechnology company targeting the human immune synapse with a new generation of monoclonal and…

July 8, 2019 Off

CTD Appoints Head of Global Regulatory Affairs

By BusinessWire

ALACHUA, Fla.–(BUSINESS WIRE)–CTD Holdings, Inc. (OTCQB: CTDH), a clinical stage biotechnology company that develops cyclodextrin-based products for the treatment of…

July 8, 2019 Off

CTD Appoints Head of Global Regulatory Affairs

By BusinessWire

ALACHUA, Fla.–(BUSINESS WIRE)–CTD Holdings, Inc. (OTCQB: CTDH), a clinical stage biotechnology company that develops cyclodextrin-based products for the treatment of…

July 8, 2019 Off

Anika Appoints James Loerop as Executive Vice President of Business Development and Strategic Planning

By BusinessWire

Industry veteran brings extensive experience leading business development groups BEDFORD, Mass.–(BUSINESS WIRE)–Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated orthopedic…

Posts pagination

Previous 1 … 3,024 3,025 3,026 … 3,606 Next

JOIN OUR COMMUNITY

Proudly powered by WordPress | Theme: Envo Magazine